Location History:
- Beerse, BE (2022)
- Antwerp, BE (2010 - 2024)
Company Filing History:
2 out of 2,077 
1 out of 410 
1 out of 832,812 Years Active: 2010-2024
Title: The Innovations of Johannes Wilhelmus John Fitzgerald Thuring
Introduction
Johannes Wilhelmus John Fitzgerald Thuring is a notable inventor based in Antwerp, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways. With a total of four patents to his name, Thuring's work has the potential to impact the treatment of various diseases.
Latest Patents
Thuring's latest patents include innovative compounds such as pyrazole derivatives that act as MALT1 inhibitors. These compounds are designed to treat diseases, syndromes, conditions, and disorders influenced by the modulation of MALT1. Another significant patent involves cyclic dinucleotides as STING agonists, which are aimed at treating diseases affected by the modulation of the STING pathway. Both patents showcase his commitment to advancing medical science through innovative chemical solutions.
Career Highlights
Throughout his career, Thuring has worked with prominent companies in the pharmaceutical industry, including Janssen Pharmaceutica and Janssen Biotech. His experience in these organizations has allowed him to collaborate on groundbreaking research and development projects that contribute to the advancement of healthcare.
Collaborations
Thuring has collaborated with esteemed colleagues such as Peter J Connolly and James Patrick Edwards. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of effective therapeutic solutions.
Conclusion
Johannes Wilhelmus John Fitzgerald Thuring is a distinguished inventor whose work in pharmaceuticals has led to the development of important patents. His contributions to the field demonstrate the impact of innovative thinking in addressing complex medical challenges.